Geneos Wealth Management Inc. Vir Biotechnology, Inc. Transaction History

Geneos Wealth Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$23.2 - $27.29 $1,392 - $1,637	60 New	60 $1,000
Q3 2022 Nov 14, 2022	SELL	$18.26 - $31.1 $10,956 - $18,660	-600 Reduced 90.91%	60 $1,000
Q4 2021 Feb 09, 2022	BUY	$30.97 - $54.03 $6,194 - $10,806	200 Added 43.48%	660 $27,000
Q3 2021 Nov 09, 2021	BUY	$34.9 - $54.54 $16,054 - $25,088	460 New	460 $15,000
Q4 2020 May 19, 2021	SELL	$25.51 - $43.38 $2,551 - $4,338	-100 Closed	0 $0
Q2 2020 Sep 07, 2021	BUY	$27.89 - $47.86 $2,789 - $4,786	100 New	100 $3,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.